Printer Friendly

R.P. SCHERER COMMENTS ON TODAY'S TRADING ACTIVITY OF ITS COMMON STOCK

R.P. SCHERER COMMENTS ON TODAY'S TRADING ACTIVITY OF ITS COMMON STOCK
 TROY, Mich., Aug. 21 /PRNewswire/ -- At the request of the New York Stock Exchange, based on today's trading volume of its common stock, R.P. Scherer (NYSE: SHR) was asked to comment. Today's trading volume was 139,200 share, triple the average daily trading volume, and less than 1 percent of Scherer's outstanding number of common shares.
 Responding to Exchange's request, Scherer said that the company knows of no corporate developments to account for the unusual market activity.
 R.P. Scherer Corporation, a leading international developer and manufacturer of drug delivery systems, is the world's largest producer of soft gelatin capsules ("softgels"). The company is currently developing and commercializing advanced drug delivery systems, including SCHERERSOL(R), ZYDIS(R) and PULSINCAP(TM) technologies. The company's proprietary drug delivery systems improve the efficacy of drugs by regulating the dosage, rate of absorption and place of release. The company operates a global network of 15 facilities in 11 countries.
 -0- 8/21/92
 /CONTACT: Aleksandar Erdeljan of R.P. Scherer Corporation, 313-649-0900/
 (SHR) CO: R.P. Scherer Corporation ST: Michigan IN: MTC SU:


KR -- DE029 -- 2312 08/21/92 17:25 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 21, 1992
Words:201
Previous Article:HCA TO SELL BAYTOWN, TEXAS, HOSPITAL; SALE TO RESULT IN EPS CHARGE OF $.10 PER SHARE
Next Article:TOYOTA ANNOUNCES SPECIAL CUSTOMER ASSISTANCE PROGRAM FOR CAMRY OWNERS DURING POWER DOOR LOCK INVESTIGATION
Topics:


Related Articles
R.P. SCHERER REPORTS THIRD-QUARTER FINANCIAL RESULTS
R.P. SCHERER REPORTS FISCAL YEAR 1992 FINANCIAL RESULTS
SCHERER ANNOUNCES AN INITIAL PUBLIC OFFERING OF ITS SUBSIDIARY, PACO PHARMACEUTICAL SERVICES, INC.
SCHERER AND PACO ANNOUNCE SUCCESSFUL COMPLETION OF INITIAL OFFERING OF PACO'S COMMON STOCK
SCHERER ANNOUNCES A SECONDARY OFFERING AND FILES A REGISTRATION STATEMENT
SCHERER ANNOUNCES PLANS TO FILE SECONDARY OFFERING
R.P. SCHERER REPORTS SECOND QUARTER FINANCIAL RESULTS
R.P. SCHERER ANNOUNCES PUBLIC OFFERING OF ITS COMMON STOCK
Cardinal Health Shareholders Approve R. P. Scherer Merger
Ex R.P. Scherer Chairman and Chief Executive Officer, Alex Erdeljan joins board of Eurand.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters